1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Clinigen Group plc
  6. News
  7. Summary
    CLIN   GB00B89J2419

CLINIGEN GROUP PLC

(CLIN)
End-of-day quote. End-of-day quote London Stock Exchange - 04/04
925 GBX   0.00%
04/05CLINIGEN : Triton Acquisition of Clinigen
PU
04/04FORM 8.3 - AXA INVESTMENT MANAGERS : Clinigen Group Plc
AQ
04/04Triton Funds Company Completes Takeover Of Clinigen
MT
SummaryQuotesChartsNewsRatingsCalendarCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

UK's Clinigen agrees to sweetened $1.8 billion Triton take-private deal

01/17/2022 | 03:27am EDT

(Reuters) - Britain's Clinigen Group Plc has agreed to a sweetened takeover offer by UK-based private equity firm Triton, valuing the pharmaceutical services firm at about 1.3 billion pounds ($1.78 billion).

Shareholders in Clinigen, whose top investor is hedge fund Elliott, will receive 925 pence per share in cash, up from a December bid of 883 pence apiece.

New York-based Elliott, which had been raising its holding in Clinigen over the past few months amid reports it was seeking a break-up of the group, owns a 10.5% stake in the British company, according to Refintiv Eikon data.

The latest offer by Triley Bidco, a newly created company indirectly owned by Triton Funds, is final and is recommended by the Clinigen board, the companies said in a joint statement.

Triton's first offer made in December valued Clinigen, which provides healthcare professionals and their patients with access to medicines, at about 1.2 billion pounds.

($1 = 0.7314 pounds)

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Rashmi Aich and Subhranshu Sahu)


© Reuters 2022
All news about CLINIGEN GROUP PLC
04/05CLINIGEN : Triton Acquisition of Clinigen
PU
04/04FORM 8.3 - AXA INVESTMENT MANAGERS : Clinigen Group Plc
AQ
04/04Triton Funds Company Completes Takeover Of Clinigen
MT
04/04Triton Fund V SCSP, Triton Fund V L.P., Triton Fund V F&F No. 5 SCSp, Triton Fund V F&F..
CI
03/31UK's High Court Approves Clinigen's Takeover
MT
03/29Form 8.3 - - (CGWL)
AQ
03/28Form 8.3 - - (CGWL)
AQ
03/28HSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
AQ
03/23Form 8.3 - Clinigen Group plc
AQ
03/23ELLIOTT INVESTMENT MANAGEMENT, L.P : Form 8.3 - Clinigen Group PLC
AQ
More news
Analyst Recommendations on CLINIGEN GROUP PLC
More recommendations
Chart CLINIGEN GROUP PLC
Duration : Period :
Clinigen Group plc Technical Analysis Chart | CLIN | GB00B89J2419 | MarketScreener
Managers and Directors
Shaun Edward Chilton Chief Executive Officer & Executive Director
Richard Paling Chief Financial Officer & Financial Controller
Elmar J. Schnee Independent Non-Executive Chairman
Ivo Timmermans Chief Medical Officer
Samuel Gordon Herbert Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
CLINIGEN GROUP PLC1.04%1 608
GILEAD SCIENCES, INC.-12.08%80 075
REGENERON PHARMACEUTICALS, INC.4.69%71 235
VERTEX PHARMACEUTICALS17.76%66 136
WUXI APPTEC CO., LTD.-17.77%42 735
BIONTECH SE-36.77%39 612